Want to see XXII full AI Analyst Report?
XXII Stock Chart & Stats
$3.04
-$0.13(-3.04%)
At close: 4:00 PM EDT
$3.04
-$0.13(-3.04%)
Day’s Range― - ―
52-Week Range$1.67 - $646.50
Previous Close$3.97
Volume14.18K
Average Volume (3M)35.33K
Market Cap
$1.28M
Enterprise Value-$3.46
Total Cash (Recent Filing)$6.06M
Total Debt (Recent Filing)$1.30M
Price to Earnings (P/E)―
Beta2.25
Next Earnings
Nov 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-114.68
Shares Outstanding713,994
10 Day Avg. Volume65,709
30 Day Avg. Volume35,332
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)2.70
Price to Sales (P/S)6.03
P/FCF Ratio-4.95
Enterprise Value/Market Cap>-0.01
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-18
Revenue Forecast (FY)$32.50M
Bulls Say, Bears Say
Bulls Say
Expanding Low-nicotine Retail DistributionBroader retail distribution can improve product availability, consumer awareness, and repeat purchases in the emerging low-nicotine category. If execution continues, the larger footprint may support more durable branded revenue and better operating leverage over the next several quarters.
Potentially Higher-margin Branded MixA greater contribution from branded products could strengthen economics compared with lower-margin activity and create more lasting customer relationships. Improving same-store sales and repeat purchases also provide evidence that distribution growth may be translating into deeper consumer adoption.
Improved Balance-sheet CapitalizationLow leverage and restored positive equity provide greater financial flexibility than the company previously had, reducing balance-sheet pressure while management pursues commercialization. This cleaner capital structure may help preserve resources for operations and strategic growth, despite continuing losses.
Bears Say
Sustained Unprofitable OperationsNegative gross profit indicates the current business model is not yet covering product costs, while the deeply negative net margin shows substantial losses remain after operating expenses. Without durable margin improvement, revenue growth alone may not translate into self-sustaining earnings.
Continued Cash Burn And Financing DependencePersistent operating and free-cash-flow deficits mean the company is not currently funding itself through operations. Continued cash burn can restrict investment in distribution and commercialization, while increasing reliance on external financing and raising execution risk over the medium term.
Loss Of Contract Manufacturing BusinessThe scheduled end of this manufacturing engagement could reduce production volumes and customer-related revenue, while also creating capacity-utilization pressure. Replacing the business will require new contracts or stronger branded demand, adding execution risk during the company’s broader repositioning.
22nd Century News
XXII FAQ
What was 22nd Century’s price range in the past 12 months?
22nd Century lowest stock price was $1.67 and its highest was $646.50 in the past 12 months.
What is 22nd Century’s market cap?
22nd Century’s market cap is $1.28M.
When is 22nd Century’s upcoming earnings report date?
22nd Century’s upcoming earnings report date is Nov 10, 2026 which is in 53 days.
How were 22nd Century’s earnings last quarter?
22nd Century released its earnings results on Aug 13, 2026. The company reported -$15.6 earnings per share for the quarter.
Is 22nd Century overvalued?
According to Wall Street analysts 22nd Century’s price is currently Overvalued.
Does 22nd Century pay dividends?
22nd Century does not currently pay dividends.
What is 22nd Century’s EPS estimate?
22nd Century’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does 22nd Century have?
22nd Century has 713,994 shares outstanding.
What happened to 22nd Century’s price movement after its last earnings report?
22nd Century reported an EPS of -$15.6 in its last earnings report. Following the earnings report the stock price went down -4.64%.
Which hedge fund is a major shareholder of 22nd Century?
Currently, no hedge funds are holding shares in XXII
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
22nd Century
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.
XXII Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call conveyed cautious optimism: management reported clear early commercial progress with sequential revenue growth, gross loss improvement, strategic retail distribution wins, regulatory validation (FDA authorization) and a stable cash position. However, material challenges remain — operating losses and negative adjusted EBITDA widened, profitability is below targets, low-margin contracts persist, and retail adoption is uneven. Management plans focused investments in marketing and distribution with a target of ~5,000 outlets by year-end, but execution risk and competitive headwinds mean near-term results may continue to be pressured.View all XXII earnings summariesTechnical Analysis
Universal
―
Turning Point Brands
―
Greenlane Holdings
―
Kaival Brands Innovations Group
―
Ispire Technology, Inc.
―
Ownership Overview
35.47% Insiders
0.65% Mutual Funds
4.84% Other Institutional Investors
59.03% Public Companies and
Individual Investors